Evidence map›Paper›PMID 40521256›Full record

ArticleWorld journal of gastroenterology2025

Vonoprazan and proton pump inhibitors: Which is superior for

Mubin Ozercan, Ahmed Tawheed, Alaa Ismail, Mohab Sherif Amer, Mohamed El-Kassas

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mubin OzercanDepartment of Gastroenterology, Firat University, Elazig 23119, Türkiye.
Ahmed TawheedDepartment of Endemic Medicine, Helwan University, Cairo 11795, Egypt.
Alaa IsmailFaculty of Medicine, Helwan University, Cairo 11795, Egypt.
Mohab Sherif AmerFaculty of Medicine, Helwan University, Cairo 11795, Egypt.
Mohamed El-KassasDepartment of Endemic Medicine, Helwan University, Cairo 11795, Egypt. m_elkassas@hq.helwan.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsHelicobacter InfectionsHelicobacter pyloriProton Pump InhibitorsPyrrolesSulfonamidesDrug Therapy, CombinationGastric AcidHumansTreatment Outcome1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamineAnti-Bacterial AgentsProton Pump InhibitorsPyrrolesSulfonamidesAcid-related disordersHelicobacter pyloriPotassium competitive acid blockersProton pump inhibitorsVonoprazan

Identifiers

PMID40521256
PMCPMC12159979

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.